Georgia Medicare Blood Services Coverage

::: hero

Georgia Medicare Blood Services

By Brevy Care Team · Last verified May 13, 2026

Blood transfusion is one of the highest-volume medical procedures in American medicine. Approximately 14 million units of blood components are transfused annually in the United States, of which approximately 5 million units are transfused to Medicare beneficiaries each year. The Medicare population's transfusion burden is substantially higher than the population average because older adults undergo more surgical procedures (cardiac surgery, joint replacement, vascular surgery), face higher rates of chronic conditions causing anemia (myelodysplastic syndromes, chronic kidney disease, hematologic malignancies), and experience higher rates of acute hemorrhage requiring transfusion support. Despite this clinical volume, Medicare's coverage rules for blood are among the most unusual in the entire benefit catalog, with cost-sharing expressed in physical units (pints) rather than dollars and rules essentially unchanged from the original 1965 Medicare statute.

The framework rests on a pair of parallel statutory provisions. Section 1813(a)(2) of the Social Security Act establishes the Part A inpatient blood deductible: a beneficiary is responsible for the first three pints of whole blood (or equivalent quantities of packed red blood cells) furnished during a spell of illness, unless those pints are replaced through donation. Section 1833(b)(1) of the Social Security Act establishes the parallel Part B outpatient blood deductible: a beneficiary is responsible for the first three pints of whole blood (or equivalent packed red blood cells) furnished under Part B during a calendar year, again subject to replacement reduction. The implementing regulations appear at 42 CFR 411.31 (Part A) and 42 CFR 410.63 (Part B), with broader operational provisions at 42 CFR 410.61 (Part B blood items) and 42 CFR 409.87 (inpatient blood).

A crucial operational point structures the entire framework: the blood deductible applies only to the "whole blood pints" themselves (the physical donor units of red blood cells, costing $40 to $80 per pint in 2026 hospital acquisition cost). The processing fees (typing, crossmatching, antibody screening, leukoreduction, irradiation when needed, CMV-negative selection when needed) and administration costs (the nursing labor of infusing the unit, monitoring, documentation) are NOT subject to the deductible and are covered from the first pint onward. The processing and administration fees typically dwarf the unit cost itself; a complete transfusion may cost $400 to $600 in total, of which only $40 to $80 is the deductible-subject portion.

Beneficiaries can satisfy the blood deductible through three pathways. First, replacement: the beneficiary or another donor on the beneficiary's behalf donates an equal number of pints of blood to the supplying blood bank, reducing the deductible pint-for-pint. This was the dominant mechanism in the 1960s and 1970s. Second, payment: the beneficiary pays the hospital's customary charge for the pint, typically $40 to $80. Third, hospital absorption: the hospital chooses not to enforce the deductible and absorbs the cost in the broader DRG-based payment economics, which is the dominant mechanism for inpatient transfusions today. In practice, the blood deductible has limited financial impact on most beneficiaries due to widespread DRG absorption for inpatients and Medigap coverage for outpatients.

The framework treats different blood components differently. Whole blood and packed RBCs are subject to the three-pint deductible. Platelets, fresh frozen plasma, cryoprecipitate, and other blood components are NOT subject to the deductible and are covered under standard cost-sharing. Factor concentrates, albumin, and immune globulin are covered under Part B drug provisions (J-codes) rather than the blood framework. Apheresis procedures (plasmapheresis, red cell exchange, leukapheresis) are covered under standard Part B with CPT codes 36511 through 36516 and typically do not engage the blood deductible.

In Georgia, the rules play out through a network of blood collection organizations including the American Red Cross Southeast Region (approximately 40 percent of state supply), LifeSouth Community Blood Centers, The Blood Connection, Vitalant, and many hospital-based blood banks at major systems including Emory, Wellstar, Piedmont, Augusta University Health, Memorial Health Savannah, and Atrium Health Navicent. The Georgia Trauma Care Network Commission coordinates blood readiness for trauma response across seven Level I and multiple Level II trauma centers statewide. The FDA regulates blood safety under 21 CFR Part 606 (Current Good Manufacturing Practice for Blood and Blood Components) and 21 CFR Part 640 (Additional Standards for Human Blood and Blood Products), while AABB (the Association for the Advancement of Blood and Biotherapies) accredits transfusion services to detailed quality standards.

This guide walks through each layer of the framework: the Part A and Part B blood deductibles, the whole-blood-versus-processing-fee distinction, the three pathways to satisfy the deductible, the coordination between Part A and Part B, the specific treatment of blood components, autologous donation coverage, the HCPCS coding architecture, and the Georgia blood banking landscape. Six Georgia case studies illustrate the most common patient situations: CABG surgery with 6-unit transfusion under DRG bundling, chronic MDS outpatient transfusion with engaged Part B deductible, pre-operative autologous donation for joint surgery, acute GI bleed admission with multi-unit transfusion, chronic anemia outpatient maintenance, and trauma transfer with massive transfusion protocol. Fourteen common mistakes are identified along the way. A 25-question accordion FAQ and a CTA with 20 contacts close the guide. :::

::: callout

Key takeaways for Georgia Medicare beneficiaries

1. Section 1813(a)(2) establishes the Part A inpatient blood deductible. The first three pints of whole blood (or equivalent packed RBCs) per spell of illness are beneficiary responsibility. Replacement reduces the deductible pint-for-pint. The rule dates from the original 1965 Medicare statute.

2. Section 1833(b)(1) establishes the parallel Part B outpatient blood deductible. The first three pints of whole blood (or equivalent packed RBCs) per calendar year under Part B are beneficiary responsibility. The deductible is separate from but coordinated with the Part A deductible.

3. The deductible applies to whole-blood pints only. Processing fees (typing, crossmatching, leukoreduction, irradiation, administration labor) are NOT subject to the deductible and are covered from the first pint. The processing/administration cost typically far exceeds the pint cost.

4. Three pathways satisfy the deductible. Replacement (donor blood credited pint-for-pint), payment (beneficiary pays hospital charge of $40 to $80 per pint), or hospital absorption (most common for inpatient via DRG bundling).

5. Platelets, plasma, cryoprecipitate are NOT subject to the deductible. Only whole blood and packed RBCs trigger the three-pint deductible. Other blood components are covered under standard cost-sharing.

6. The deductibles coordinate across Part A and Part B. Pints satisfied under one part count toward the other for the same year. The total deductible is three pints per spell of illness (Part A) or per calendar year (Part B), not three under each.

7. Medigap covers the blood deductible. All standardized Medigap plans (A, B, D, G, K, L, M, N) cover the blood deductible to varying degrees. Beneficiaries with Medigap typically have $0 out-of-pocket for blood services.

8. Georgia is served by multiple blood organizations. American Red Cross Southeast Region, LifeSouth Community Blood Centers, The Blood Connection, and hospital-based blood banks together supply the state. FDA regulates blood safety; AABB accredits transfusion services. :::

The clinical case for understanding Medicare blood coverage

Before the legal framework, the clinical stakes deserve a moment of attention. Blood transfusion is among the most common medical procedures in the United States. The volume reflects the broad applications of transfusion across modern medicine:

Surgical transfusion support. Cardiac surgery (CABG, valve replacement), orthopedic surgery (hip and knee replacement, revision surgery, spine surgery, complex trauma), vascular surgery (aortic aneurysm repair, peripheral revascularization), and major abdominal surgery commonly require transfusion. Patient blood management programs have reduced transfusion rates over the past two decades, but the absolute volume remains substantial.

Chronic anemia management. Myelodysplastic syndromes (MDS), chronic kidney disease (when erythropoiesis-stimulating agents are inadequate), chronic inflammatory conditions, sickle cell disease, and beta thalassemia commonly require ongoing transfusion support. MDS patients may require 1 to 4 units of packed RBCs every 2 to 4 weeks indefinitely.

Acute hemorrhage. Upper and lower gastrointestinal bleeding, postpartum hemorrhage (in younger Medicare beneficiaries via disability), traumatic injury, ruptured aneurysm, and severe surgical bleeding require urgent transfusion. Massive transfusion protocols (MTP) coordinate the delivery of packed RBCs, plasma, and platelets in 1:1:1 ratios for hemorrhagic shock.

Cancer treatment. Chemotherapy-induced cytopenias commonly require transfusion support. Hematologic malignancies (acute leukemia, lymphoma, multiple myeloma) often require extensive transfusion during induction, consolidation, and stem cell transplantation.

For older adults, the cumulative transfusion exposure can be substantial. A patient undergoing CABG followed by chronic MDS management may receive hundreds of units over several years. Understanding the Medicare coverage rules helps beneficiaries and their families know what to expect from a cost-sharing perspective and how to ensure that medically necessary transfusion support is properly billed and covered.

Statutory authority: Section 1813(a)(2) Part A blood deductible

Section 1813(a) of the Social Security Act establishes cost-sharing for Part A services. Subsection (a)(2) is specifically devoted to the blood deductible:

"The amount payable for inpatient hospital services... furnished an individual during any spell of illness shall be reduced... by a deduction equal to the amount of the customary charges of the hospital with respect to the first 3 pints of whole blood (or equivalent quantities of packed red blood cells, as defined under regulations) furnished to the individual during the spell of illness; except that such deduction for any pint of blood shall be appropriately reduced to the extent that there has been a replacement of such pint of blood..."

Several features deserve attention.

First, the deductible is per "spell of illness" or benefit period. A spell of illness begins on the first day of inpatient hospital admission and ends after 60 consecutive days without inpatient hospital or skilled nursing facility care. A beneficiary who has multiple distinct hospitalizations with intervening 60-day gaps could face the blood deductible in each spell of illness.

Second, the deductible is expressed as "the amount of the customary charges of the hospital" for the first three pints. In practice, this means the hospital's actual blood acquisition cost, which varies by hospital and region. Typical 2026 hospital acquisition cost for one unit of packed red blood cells is $40 to $80, though some hospitals pay more or less based on supply contracts.

Third, the rule has not changed since the original 1965 statute. While the dollar deductibles for Part A inpatient hospital ($1,676 in 2026) and Part B annual ($257 in 2026) are updated yearly, the three-pint blood deductible has remained constant. Some specialists in Medicare history note that the 1965 statute's blood deductible reflects the era's blood-banking model (community replacement-based donation) that has largely disappeared.

Fourth, replacement reduces the deductible. The original mechanism: the beneficiary or another donor would donate replacement blood to the supplying blood bank, and each replaced pint reduced the deductible by one pint.

Statutory authority: Section 1833(b)(1) Part B blood deductible

Section 1833(b)(1) of the Social Security Act establishes the parallel Part B outpatient blood deductible:

"Before applying subsection (a) with respect to expenses incurred by an individual, there shall be excluded from such expenses... the expenses incurred for the first 3 pints of whole blood (or equivalent quantities of packed red blood cells, as defined under regulations) received under part B during the calendar year, except that such deduction for any such pint of blood shall be appropriately reduced to the extent that there has been a replacement of such pint of blood..."

The Part B blood deductible is per calendar year. The structure mirrors the Part A deductible: the first three pints of whole blood (or equivalent packed RBCs) are the beneficiary's responsibility; replacement reduces the deductible pint-for-pint.

The Part B blood deductible is separate from and unrelated to the standard Part B annual deductible ($257 in 2026). A beneficiary receiving an outpatient transfusion in 2026 may face both: the standard $257 Part B deductible plus up to three pints of blood deductible.

The Part B and Part A blood deductibles are coordinated. If the beneficiary satisfies the deductible under one part during a year (or benefit period), the satisfaction applies to the other for the same year. This prevents double-deductible imposition when a beneficiary has both inpatient and outpatient transfusions during the same year.

Implementing regulations: 42 CFR 411.31 and 42 CFR 410.63

42 CFR 411.31: Part A blood deductible

42 CFR 411.31 implements the Part A blood deductible established in Section 1813(a)(2). Key provisions:

• The blood deductible applies to the first three pints of whole blood (or equivalent units of packed red blood cells) furnished during a spell of illness
• The deductible is satisfied by replacement, payment, or hospital absorption
• Coordination with Part B prevents double-deductible imposition
• The deductible is administered by the hospital and reflected in claim documentation

42 CFR 410.63: Part B blood deductible

42 CFR 410.63 implements the Part B blood deductible established in Section 1833(b)(1). Key provisions:

• The blood deductible applies to the first three pints of whole blood (or equivalent units of packed red blood cells) furnished under Part B during a calendar year
• The deductible is in addition to the standard Part B annual deductible
• Replacement reduces the deductible pint-for-pint
• Coordination with Part A prevents double-deductible imposition

42 CFR 410.61: Part B blood items

42 CFR 410.61 addresses Part B coverage of blood and blood-derived products. The regulation:

• Defines covered blood items (whole blood, packed RBCs, plasma, platelets, cryoprecipitate, granulocytes, factor concentrates)
• Establishes that the blood deductible applies to whole blood and packed RBCs but NOT to processing fees or to other blood components
• Lists specific exceptions and coverage details

42 CFR 409.87: inpatient blood

42 CFR 409.87 addresses Part A coverage of blood furnished during inpatient stays. The regulation:

• Establishes that inpatient blood is generally covered as part of inpatient hospital services
• Specifies that the blood deductible is administered by the hospital
• Coordinates with the broader Part A inpatient hospital benefit framework

The whole-blood-versus-processing-fee distinction

The crucial operational point of the Medicare blood framework: the deductible applies only to the "whole blood pints" (or equivalent packed RBC units). The processing and administration fees are NOT subject to the deductible and are covered from the first pint onward.

What are processing fees? The labor, supplies, and technical work involved in:

• Blood typing (ABO and Rh)
• Antibody screening and identification
• Crossmatching (compatibility testing between donor and recipient)
• Leukoreduction (removing white blood cells to reduce febrile reactions)
• Irradiation (preventing transfusion-associated graft-versus-host disease in immunocompromised patients)
• CMV-negative selection (for at-risk patients including organ transplant recipients)
• Pathogen inactivation (when applicable)
• Storage and handling
• Administration (the actual transfusion procedure by nurses, including monitoring)

These technical fees are typically more expensive than the blood unit itself. A typical packed RBC transfusion in 2026 may have the following cost components:

• Blood unit (subject to deductible): $40 to $80
• Typing and crossmatching: $40 to $80
• Leukoreduction: $30 to $50 (often built into the unit cost)
• Irradiation (if needed): $30 to $50
• CMV-negative (if needed): minimal incremental cost
• Administration (nursing labor, supplies, monitoring): $80 to $150
• Total transfusion cost: $200 to $500 per unit

Of this $200 to $500 total, only $40 to $80 is the deductible-subject portion. The remaining cost is covered from the first pint under standard cost-sharing (20 percent Part B coinsurance after deductible for outpatient transfusion, or bundled in DRG for inpatient).

Hospitals generally bill the blood unit and processing fees on separate revenue codes. Medicare claim processing recognizes the distinction and applies the deductible only to the whole-blood-pint portion.

Three pathways to satisfy the blood deductible

The 1965 statute envisioned three pathways for beneficiaries to satisfy the blood deductible.

Pathway one: replacement (the original mechanism)

The beneficiary or another donor on the beneficiary's behalf donates an equal number of pints of replacement blood to the supplying blood bank. Each pint of replacement blood reduces the deductible by one pint.

Replacement was the dominant mechanism in the 1960s and 1970s. Many communities had "blood credit" systems through community blood banks where family and friends could donate to "replace" blood used by a patient. Some employers ran blood donation drives that gave employees credits for future patient needs.

Replacement is much less common today. Several factors have reduced its role:

• Hospital blood banking has consolidated, and replacement-eligible donors must donate at specific approved blood banks
• Donor eligibility criteria have become more restrictive (age limits, health screening, deferrals for travel and behavior, low hemoglobin)
• Community blood drives have shifted toward general supply rather than patient-specific replacement
• Some hospitals no longer accept "replacement" donations as administrative simplification
• The widespread availability of insurance coverage (Medigap, MA plans) has reduced the financial incentive to replace

Beneficiaries who want to replace blood should ask the hospital's blood bank manager about specific replacement procedures. The replacement must typically occur at the specific blood bank that supplied the patient or a participating affiliated bank.

Pathway two: payment

The beneficiary pays the hospital's customary charge for the pint. In 2026, this is typically $40 to $80 per pint of packed red blood cells (whole blood pints are rarely collected anymore; nearly all transfusions use packed RBCs). The hospital bills the beneficiary directly; the beneficiary pays out of pocket or through supplemental insurance.

Medigap policies cover the blood deductible to varying degrees:

• Plan A: Includes coverage for three pints of blood (one of the basic benefits in all Medigap plans)
• Plan B through Plan N: All include three pints of blood coverage
• Specific plan variations: Some plans cover the deductible at 100 percent; others at 50 to 75 percent (Plans K and L)

For most beneficiaries with Medigap, the blood deductible is covered in full or near-full by the supplemental policy.

Pathway three: hospital absorption

Many hospitals choose not to enforce the three-pint deductible aggressively. They include the cost of blood in the hospital's overall operating cost and absorb the cost rather than billing the beneficiary. This is administratively simpler and avoids friction with patients during an already stressful hospitalization.

For inpatient transfusions, the DRG-based payment includes the cost of blood. The hospital receives a flat DRG payment regardless of how much blood was used during the admission. The hospital's economics of blood use are managed at the DRG level rather than per-pint. Most hospitals administratively satisfy the deductible through this absorption pathway for inpatient transfusions.

For Part B outpatient transfusions (outpatient hospital settings, outpatient cancer infusion centers, dialysis centers, ASCs), the situation varies. Some Part B providers absorb the cost; others bill the beneficiary the deductible. Beneficiaries receiving regular outpatient transfusions for chronic conditions (MDS, chronic anemia, hematologic malignancy maintenance therapy) are most likely to actually face the Part B blood deductible.

Coordination of Part A and Part B blood deductibles

The Part A and Part B blood deductibles are coordinated to prevent double-deductible imposition. The coordination rules:

• If a beneficiary satisfies pints under Part A during a benefit period, the satisfaction applies to Part B for the same calendar year up to three total pints
• If a beneficiary satisfies pints under Part B during a calendar year, the satisfaction applies to subsequent Part A admissions in the same calendar year up to three total pints
• The total deductible is three pints per benefit period (Part A) or per calendar year (Part B), not three pints under each

For example, suppose a Georgia beneficiary has an inpatient admission in February with 2 pints of blood (Part A deductible: 2 pints) and an outpatient transfusion in August of 3 pints (Part B). Only 1 pint of the August outpatient transfusion would count against the deductible (the other 2 pints are credited from the prior Part A deductible satisfaction). The beneficiary's total exposure is 3 pints across the year, not 6 pints.

Blood components and the deductible scope

The blood deductible applies specifically to whole blood and equivalent quantities of packed red blood cells. It does NOT apply to other blood components:

• Platelets: Not subject to the three-pint deductible. Covered under standard cost-sharing. A patient receiving platelet transfusions for chemotherapy-induced thrombocytopenia faces no blood deductible regardless of the number of platelet units received.

• Fresh frozen plasma (FFP): Not subject to the three-pint deductible. Covered under standard cost-sharing.

• Cryoprecipitate: Not subject to the three-pint deductible. Covered under standard cost-sharing.

• Granulocytes: Not subject to the three-pint deductible (rarely used in modern transfusion medicine).

• Factor concentrates (e.g., factor VIII, factor IX, factor VIIa): Not subject to the blood deductible. Covered under Part B drug provisions with appropriate J-codes.

• Albumin and immune globulin: Treated as plasma derivatives. Covered under Part B drug provisions.

• Specific antibody preparations (e.g., Rh immune globulin): Covered under Part B drug provisions.

The narrow scope of the deductible (whole blood and packed RBCs only) is one reason it has limited practical impact for most beneficiaries. The most common scenario where the deductible actually engages is chronic outpatient packed RBC transfusion for conditions like MDS.

Autologous blood donation

Autologous donation refers to the beneficiary donating their own blood for their own later use, typically before elective surgery. The autologous unit is stored and returned to the patient if needed during the surgery.

Pre-operative autologous donation

The collection, processing, storage, and re-infusion of the patient's own blood is covered when medically appropriate. The patient's own blood pints satisfy the blood deductible per the replacement mechanism (the patient is donating to replace what they will use).

Medical appropriateness considerations for pre-operative autologous donation:

• Patients with rare blood types or multiple alloantibodies that make compatible allogeneic transfusion difficult
• Patients with strong religious objections to allogeneic transfusion (when autologous is acceptable)
• Patients undergoing major procedures where the probability of transfusion is high
• Patients in good general health who can tolerate the pre-operative donation without risk

Pre-operative autologous donation has declined since the 1990s peak. Several factors have reduced its role:

• Modern transfusion thresholds are lower (hemoglobin 7 to 8 g/dL threshold for elective transfusion in stable patients)
• Allogeneic blood is safer than ever, with very low rates of transfusion-transmitted infection
• Autologous units have higher wastage rates (60 percent or more of pre-operative autologous units are not transfused and are wasted)
• Patient blood management programs have reduced overall surgical transfusion volumes
• Cost-effectiveness analyses have shown that pre-operative autologous donation is rarely cost-effective compared to allogeneic transfusion

Intra-operative autologous recovery (cell salvage)

Devices that collect surgical blood loss, wash it, and re-infuse it to the patient are covered when medically appropriate. This is increasingly common in cardiac surgery, complex spine surgery, vascular surgery, and major orthopedic surgery. The cell salvage approach has largely supplanted pre-operative autologous donation in many surgical contexts.

Acute normovolemic hemodilution (ANH)

Removing the patient's blood at the start of surgery, replacing the volume with crystalloid or colloid, then re-infusing the patient's blood during or after surgery, is covered when medically appropriate. ANH is used in some cardiac, vascular, and orthopedic procedures.

HCPCS coding for blood services

Blood unit codes (P-codes)

Blood collection and processing codes

Transfusion administration codes

Therapeutic apheresis codes

Coverage for specific clinical conditions

Surgical transfusion support

Common Medicare surgeries that frequently require transfusion:

• Cardiac surgery: CABG (30 to 50 percent transfusion rate), valve replacement, complex aortic surgery
• Orthopedic surgery: Hip replacement (10 to 30 percent transfusion rate), revision hip arthroplasty, spine surgery, complex trauma
• Vascular surgery: Open aortic aneurysm repair (high transfusion rates), peripheral revascularization
• Abdominal surgery: Major hepatobiliary, pancreatic, gastric surgery, trauma laparotomy

For inpatient surgical transfusions, blood and processing costs are bundled into the DRG-based payment. The beneficiary's three-pint deductible is typically administratively satisfied through DRG inclusion. The beneficiary's primary cost-sharing exposure is the Part A inpatient deductible ($1,676 in 2026, typically covered by Medigap).

Chronic anemia management

Patients with chronic anemia from MDS, chronic kidney disease, chronic inflammatory conditions, or hematologic malignancy may require regular transfusion support. Common patterns:

• MDS: Patients with transfusion-dependent MDS may receive 1 to 4 units of packed RBCs every 2 to 4 weeks indefinitely. Annual transfusion volume can reach 25 to 50 units per year.
• CKD: Most CKD patients are managed with erythropoiesis-stimulating agents (epoetin alfa, darbepoetin alfa) rather than transfusion. Refractory patients may require occasional transfusion.
• Sickle cell disease (rare in older Medicare population): Chronic transfusion programs may be needed for stroke prevention.
• Hematologic malignancies: Patients on chronic chemotherapy may require ongoing transfusion support.

For chronic outpatient transfusions, the Part B blood deductible applies (three pints per calendar year), in addition to the standard Part B annual deductible and 20 percent coinsurance on processing and administration.

Acute hemorrhage

Patients with acute hemorrhage (GI bleeding, traumatic injury, surgical bleeding, postpartum hemorrhage) may receive massive transfusion protocol (MTP) with multiple units in coordinated ratios. For inpatient MTP, all blood and components are bundled into the DRG.

Hematologic malignancies

Patients undergoing chemotherapy or stem cell transplantation for hematologic malignancies often require extensive transfusion support:

• Acute leukemia induction: Packed RBCs and platelets typically needed throughout the 4 to 6 weeks of induction
• Allogeneic stem cell transplant: Substantial transfusion needs for 30 to 60 days post-transplant
• Autologous stem cell transplant: Lower transfusion needs but typically some support required

For inpatient transplant care, transfusion costs are bundled into the DRG. For outpatient maintenance transfusion (less common), Part B rules apply.

Apheresis procedures

Therapeutic apheresis is a specialized blood procedure where a specific component is removed and the remainder returned to the patient. Indications include:

• Plasmapheresis: Autoimmune diseases (myasthenia gravis, Guillain-Barré syndrome, TTP), monoclonal gammopathies, hyperviscosity syndrome
• Red cell exchange: Sickle cell crisis, severe hyperhemolysis
• Leukapheresis: Symptomatic hyperleukocytosis in leukemia
• Plateletpheresis: Rarely needed therapeutically
• LDL apheresis: Familial hypercholesterolemia

Apheresis is covered under standard Part B rules with CPT codes 36511 to 36516. The blood deductible does not typically apply to apheresis because the procedure does not involve donor blood transfusion in most cases (the patient's own blood is processed and returned).

The Georgia blood banking landscape

Blood collection organizations

Georgia is served by multiple blood collection organizations:

American Red Cross Southeast Region. The American Red Cross is the largest blood collection organization in Georgia, supplying approximately 40 percent of state hospital blood. Headquartered nationally in Washington, DC. Phone 1-800-RED-CROSS.

LifeSouth Community Blood Centers. Operates in Georgia, Florida, and Alabama. Headquartered in Gainesville, Florida. Phone 1-888-795-2707. Supplies many hospitals across Georgia.

The Blood Connection. Operates in Georgia, South Carolina, North Carolina, and other Southeast states. Headquartered in Piedmont, South Carolina. Phone 1-864-255-5000.

Hospital-based blood banks. Many large hospitals operate their own blood banks that collect locally and process blood internally:

• Emory Healthcare blood services
• Wellstar Health System blood services
• Piedmont Healthcare blood services
• Northside Hospital blood services
• Augusta University Health blood services
• Memorial Health Savannah blood services
• Atrium Health Navicent (Macon) blood services

Georgia trauma and blood readiness

Georgia has a comprehensive trauma care network coordinated by the Georgia Trauma Care Network Commission (404-679-0540). Trauma centers maintain elevated blood inventory for mass casualty events.

Level I trauma centers in Georgia:

• Grady Memorial Hospital (Atlanta)
• Emory University Hospital
• Wellstar Atlanta Medical Center
• Memorial Health University Medical Center (Savannah)
• Augusta University Medical Center
• Piedmont Columbus Regional
• Atrium Health Navicent (Macon)

Multiple Level II trauma centers serve regional communities. These trauma centers operate massive transfusion protocols (MTP) for major hemorrhagic events.

Blood safety oversight

Federal oversight:

• FDA: 21 CFR Part 606 (Current Good Manufacturing Practice for Blood and Blood Components) and 21 CFR Part 640 (Additional Standards for Human Blood and Blood Products). FDA inspects blood centers regularly and enforces compliance with manufacturing and donor screening standards.
• CMS: Conditions of Participation for hospitals require AABB or equivalent accreditation for blood transfusion services.

National accreditation:

• AABB (Association for the Advancement of Blood and Biotherapies): Major accrediting body for blood banks and transfusion services. AABB Standards for Blood Banks and Transfusion Services is the principal national standard. AABB phone 301-907-6977.
• CAP (College of American Pathologists): Laboratory accreditation including transfusion services.

State oversight:

• Georgia Department of Public Health: Coordinates with federal authorities on blood safety. Phone 404-657-2700.

Modern blood safety achievements

The modern blood supply is the safest in history. Major advances include:

• Nucleic acid amplification testing (NAAT) for HIV, HCV, and HBV. The viral detection window has been reduced to 5 to 10 days for HIV and HCV.
• Bacterial testing of platelets: Reduced bacterial sepsis risk.
• Pathogen reduction technology: Increasing adoption for platelets and plasma.
• Universal leukoreduction: Applied to nearly all US transfusion products since the early 2000s, reducing febrile reactions and CMV transmission.
• Babesia testing: Routine in endemic areas including some Northeast and Midwest regions.
• Trypanosoma cruzi (Chagas) screening: One-time at donor enrollment.
• West Nile virus testing: Seasonal.

Current transfusion-transmitted infection rates per unit:

• HIV: less than 1 in 1.5 million
• HCV: less than 1 in 1 million
• HBV: less than 1 in 750,000

Non-infectious transfusion reactions (febrile non-hemolytic, allergic) occur in approximately 1 in 100 to 1 in 1000 transfusions. Serious reactions (acute hemolytic, anaphylactic, transfusion-related acute lung injury, transfusion-associated circulatory overload) occur in less than 1 in 10,000 to 1 in 100,000 transfusions.

Worked example one: Margaret 78 Atlanta CABG surgery

Margaret is a 78-year-old in Atlanta scheduled for coronary artery bypass grafting (CABG) at Emory University Hospital. She has triple-vessel coronary disease with reduced ejection fraction.

Surgery and transfusion

Margaret undergoes 3-vessel CABG with cardiopulmonary bypass. Intra-operative bleeding and hemodilution require transfusion support: 6 units of leukoreduced packed RBCs, 4 units of fresh frozen plasma, and 1 pool of platelets.

Inpatient billing

• Admission DRG (cardiac surgery with major complication or comorbidity): DRG-based payment approximately $52,000
• 6 units P9016 (leukoreduced packed RBCs): bundled in DRG
• 4 units FFP, 1 platelet pool: bundled in DRG
• Processing fees, administration: bundled in DRG
• All transfusion-related costs covered by the DRG payment

Margaret's cost-sharing

• Part A inpatient deductible (2026): $1,676 (paid by Medigap Plan G)
• Three-pint blood deductible: administratively satisfied through DRG inclusion. Margaret faces $0 separate blood deductible charge.
• Daily coinsurance for hospital days 61+: not applicable (admission was 7 days)

Total Margaret out-of-pocket: $0 (Medigap covers the inpatient deductible; the blood deductible was administratively satisfied through DRG bundling).

This is the typical pattern for inpatient transfusion. The hospital's economics of blood are managed at the DRG level, and the blood deductible is essentially invisible to the beneficiary.

Worked example two: Robert 81 Savannah chronic MDS transfusion

Robert is an 81-year-old in Savannah with transfusion-dependent myelodysplastic syndrome (MDS). He receives 2 units of leukoreduced packed RBCs every 3 weeks at the Memorial Health outpatient infusion center. Annual transfusion volume: approximately 34 units PRBCs.

Each visit billing

• 2 units P9016 (leukoreduced packed RBCs): approximately $80 per unit = $160 total for blood pints
• Processing fees (typing, crossmatching, irradiation as needed): approximately $200
• Administration (CPT 36430): approximately $130
• Total approved: approximately $490 per visit

Blood deductible engagement (January and February visits)

First visit of January (units 1-2):

• 2 of 3 pints toward Part B blood deductible
• Hospital charge for the 2 pints: $160
• Robert owes the $160 blood deductible
• Plus 20 percent coinsurance on processing and administration ($66)
• Medigap Plan G covers both

Second visit of January (units 3-4):

• 1 more pint counts toward deductible (pint 3 of year)
• Hospital charge for that pint: $80
• Robert owes the $80 blood deductible
• The fourth pint is covered as Part B (20 percent coinsurance)
• All processing and administration: standard Part B coinsurance
• Medigap Plan G covers all

Subsequent visits (March through December):

• Blood deductible already met for the year
• Pints 5 through 34: covered under standard Part B cost-sharing (80 percent Medicare, 20 percent coinsurance)
• Processing and administration: standard Part B coinsurance
• Medigap Plan G covers all

Robert's annual out-of-pocket (with Medigap Plan G)

$0 (Medigap covers the blood deductible, the standard Part B deductible, and the 20 percent coinsurance).

Without Medigap

If Robert did not have Medigap, his annual out-of-pocket would be:

• Blood deductible: $240 (3 pints at $80 each)
• Part B annual deductible: $257
• 20 percent coinsurance on approximately $16,400 in annual Medicare-approved (34 visits at $490 minus the standard deductible offset): approximately $3,280

Total annual out-of-pocket without Medigap: approximately $3,780.

This illustrates the substantial financial protection Medigap provides for beneficiaries with chronic transfusion needs.

Worked example three: Linda 75 Macon hip replacement autologous donation

Linda is a 75-year-old in Macon scheduled for total hip arthroplasty at Atrium Health Navicent. She has a history of multiple alloantibodies from prior transfusions years ago that make compatible blood matching difficult. Her surgeon recommends pre-operative autologous donation as part of the transfusion-readiness plan.

Pre-operative autologous donation

Plan: donate 2 units of autologous blood at 4 weeks and 2 weeks before surgery. Store at hospital blood bank. Available for re-infusion during or after surgery if needed.

Autologous donation visits:

• CPT 86890 (autologous blood collection, processing, storage): approximately $250 per unit Medicare-approved
• 2 units total: approximately $500

Surgical hospitalization

Hip arthroplasty proceeds. Intra-operative blood loss requires transfusion of 1 unit (her first autologous unit) plus 1 unit of allogeneic packed RBCs (matched after considerable effort given antibodies).

Inpatient billing

• Hip replacement DRG: approximately $14,000
• 1 autologous unit re-infused: bundled in DRG
• 1 allogeneic PRBC: bundled in DRG
• All processing, crossmatching, administration: bundled in DRG

Linda's autologous donations satisfy the replacement pathway for the blood deductible. The autologous units count as pre-replaced.

Linda's cost-sharing

• Pre-operative autologous donation visits: 20 percent coinsurance, covered by Medigap Plan G
• Part A inpatient deductible (already met for the year): $0
• Blood deductible: administratively satisfied via DRG and autologous replacement
• Total Linda out-of-pocket: $0 (Medigap covers all coinsurance)

This example illustrates the autologous donation pathway. Pre-operative autologous donation is appropriate for patients with antibody-related transfusion complexity or rare blood types.

Worked example four: Charles 79 Augusta GI bleed admission

Charles is a 79-year-old in Augusta admitted to Augusta University Medical Center with severe upper gastrointestinal bleeding from a bleeding peptic ulcer. He presented to the ED hemodynamically unstable with hemoglobin of 6.4 g/dL.

Resuscitation and admission

• 4 units packed RBCs administered in the emergency department and intensive care unit
• Upper GI endoscopy with hemostatic clip placement for bleeding ulcer
• 5-day hospital stay
• IV proton pump inhibitor therapy

Inpatient billing

• Admission DRG (gastrointestinal hemorrhage with major complication): DRG payment approximately $14,500
• 4 units PRBCs: bundled in DRG
• Endoscopy with intervention: bundled in DRG
• Processing, administration, ICU costs: bundled in DRG

Charles's cost-sharing

• Part A inpatient deductible (2026): $1,676 (paid by Medigap Plan G)
• Blood deductible: administratively satisfied through DRG inclusion
• Daily coinsurance: not applicable (5-day stay, well under 60-day limit)

Total Charles out-of-pocket: $0 (Medigap covers the inpatient deductible).

This is the typical pattern for acute hemorrhage transfusion. The DRG bundling means the blood costs are invisible to the beneficiary.

Worked example five: Patricia 73 Columbus chronic anemia outpatient

Patricia is a 73-year-old in Columbus with chronic anemia from chronic kidney disease (stage 4) and ulcerative colitis. Her primary care physician and nephrologist together manage her care. After erythropoiesis-stimulating agents proved insufficient, the team initiated monthly outpatient transfusion of 2 units packed RBCs.

Monthly visit billing

• 2 units P9016: approximately $80 per unit = $160 for blood pints
• Processing fees: approximately $200
• Administration (CPT 36430): approximately $130
• Total approved per visit: approximately $490

January visit (visit 1)

• 2 of the 3-pint Part B deductible used (units 1-2 of year)
• Patricia owes: $160 blood deductible portion (paid by Medigap Plan G)
• Coinsurance on processing and administration: 20 percent of $330 = $66 (paid by Medigap)

February visit (visit 2)

• 1 of the 3-pint deductible used (unit 3 of year), 1 pint covered as Part B (unit 4)
• Patricia owes: $80 blood deductible portion (paid by Medigap)
• Plus coinsurance on processing, administration, and the covered blood pint (unit 4)
• Approximately $96 (paid by Medigap)

March through December (visits 3-12)

• No more blood deductible for the year
• Standard Part B coinsurance only on processing and administration
• Approximately $66 per visit coinsurance (20 percent of $330) paid by Medigap
• Blood pints (units 5-24 of year): standard 20 percent coinsurance on $80 per pint, paid by Medigap

Total Patricia out-of-pocket: $0 (all coinsurance and deductible covered by Medigap Plan G).

Without Medigap, Patricia would face approximately $240 blood deductible plus approximately $1,140 annual coinsurance, totaling approximately $1,380 per year out of pocket.

Worked example six: Henry 84 rural Tifton trauma transfer

Henry is an 84-year-old in rural Tifton involved in a serious motor vehicle accident. He was initially stabilized at the local rural hospital and transferred via medical helicopter to Memorial Health University Medical Center (Level I trauma center) in Savannah.

Trauma resuscitation

Massive transfusion protocol (MTP) initiated:

• 8 units packed RBCs
• 6 units fresh frozen plasma
• 2 pools of platelets
• 1 pool of cryoprecipitate

Multiple operative procedures over a 5-day ICU stay.

Inpatient billing (after transfer)

• Admission DRG (severe trauma with major procedures): DRG payment approximately $85,000
• All blood products (8 PRBCs, 6 FFP, 2 platelet pools, 1 cryoprecipitate): bundled in DRG
• Surgical procedures, ICU care: bundled in DRG

Henry's cost-sharing

• Part A inpatient deductible (2026): $1,676 (Henry does NOT have Medigap; he pays out of pocket)
• Blood deductible: administratively satisfied through DRG inclusion
• Air ambulance transfer: separately billed under Part B (significant out-of-pocket)

Air ambulance Part B billing:

• Approved amount: approximately $25,000 (varies)
• Medicare pays 80 percent: $20,000
• Henry's 20 percent coinsurance: $5,000 (no Medigap to cover this)

Henry has financial hardship. The hospital social worker helps him apply for financial assistance and Medicaid. Given Henry's modest income, he may qualify for QMB benefits going forward, which would cover his Medicare cost-sharing.

Total Henry out-of-pocket from this admission (before any financial assistance): approximately $6,676 ($1,676 inpatient deductible + $5,000 air ambulance coinsurance).

This case illustrates the protection afforded by the DRG bundling for blood. Despite massive transfusion (8 units PRBCs plus other components, blood cost likely $4,000 to $6,000), the beneficiary's blood-specific cost-sharing is administratively satisfied. The major out-of-pocket exposures are the Part A inpatient deductible and any unbundled Part B services like air ambulance transport.

Fourteen common mistakes in Medicare blood coverage

Mistake one: not understanding the three-pint deductible exists

Many Medicare beneficiaries are unaware that a blood deductible exists at all. The deductible has been largely invisible because most hospitals administratively absorb the cost for inpatients rather than billing patients. Beneficiaries may be surprised to see a blood charge on a bill, especially for outpatient transfusions.

Mistake two: confusing blood pints with processing fees

The blood deductible applies only to the whole blood pints (or equivalent packed RBCs), not to the processing and administration fees. Beneficiaries who see a $400 blood-related charge should understand that only $40 to $80 of that is subject to the deductible; the remaining $320 to $360 is processing and administration covered from the first pint.

Mistake three: not knowing about Medigap blood coverage

Medigap policies cover the blood deductible to varying degrees. All standardized plans (A, B, D, G, K, L, M, N) include some blood deductible coverage as a basic benefit. Beneficiaries with Medigap typically have the blood deductible covered. Beneficiaries without Medigap face the deductible out of pocket.

Mistake four: thinking platelets and plasma are subject to the deductible

The three-pint deductible applies specifically to whole blood and packed RBCs. Platelets, fresh frozen plasma, cryoprecipitate, and other blood components are NOT subject to the deductible. They are covered under standard cost-sharing.

Mistake five: assuming inpatient and outpatient deductibles are separate

The Part A and Part B blood deductibles are coordinated. A beneficiary who satisfies pints under one part receives credit toward the other. The total deductible is three pints per benefit period (Part A) or calendar year (Part B), not three under each.

Mistake six: not exploring replacement options

The replacement pathway for satisfying the deductible is little-used today but remains available. Beneficiaries with family or friends willing to donate blood may be able to satisfy the deductible through replacement at the supplying blood bank, avoiding out-of-pocket cost. The replacement must occur at the specific blood bank that supplied the patient or a participating affiliated bank.

Mistake seven: assuming Medicare covers private blood banking

Storage of one's own blood "in case of need" (private autologous blood banking) and storage of blood from specific family donors (directed donation) for routine future use are NOT generally covered by Medicare. Medicare covers blood that is medically necessary for current or near-term clinical needs.

Mistake eight: thinking autologous donation is always covered

Pre-operative autologous donation must be medically appropriate for coverage. Routine autologous donation for low-blood-loss surgery is not necessarily medically necessary. Patients with rare blood types, multiple alloantibodies, or autoimmune conditions may have stronger medical justification.

Mistake nine: not understanding DRG bundling for inpatient blood

Inpatient transfusions are bundled into the DRG payment. The hospital is paid a fixed DRG amount that includes the cost of blood and processing. The beneficiary's three-pint deductible is administratively satisfied through DRG inclusion in most cases. Beneficiaries should not expect to see a separate blood line item on most inpatient bills.

Mistake ten: confusion about Medicare Advantage blood coverage

Medicare Advantage plans must cover the same blood services as Original Medicare but may structure cost-sharing differently. Some MA plans waive the blood deductible; others apply standard plan cost-sharing structures. Beneficiaries should review their MA plan's Evidence of Coverage for specific blood coverage rules.

Mistake eleven: not knowing about transfusion appropriateness

Hospitals are increasingly measured on transfusion appropriateness. Modern guidelines recommend a hemoglobin 7 to 8 g/dL threshold for transfusion in stable patients. Beneficiaries should expect their physicians to make evidence-based transfusion decisions rather than transfusing every patient with low hemoglobin.

Mistake twelve: assuming all hospitals charge the same

Hospital blood charges vary based on supply contracts and overhead. Some hospitals charge $40 per pint while others charge $80 or more. The variation reflects market dynamics but is largely invisible to most patients due to insurance-mediated billing.

Mistake thirteen: confusing therapeutic phlebotomy with the blood deductible

Therapeutic phlebotomy (removing blood for medical reasons, as in hemochromatosis or polycythemia vera) is a medical procedure NOT subject to the blood deductible. The deductible applies to receiving blood transfusion, not to giving blood for therapeutic purposes.

Mistake fourteen: not coordinating with hospital social workers

For beneficiaries facing significant out-of-pocket costs related to blood (regular outpatient transfusions without Medigap), hospital social workers can help identify financial assistance programs, charitable foundations, and patient assistance options. Many hospitals have financial counselors who can negotiate payment plans for self-pay portions.

Coordination with Medicare Advantage

Medicare Advantage plans must cover the same blood services as Original Medicare but may structure cost-sharing differently:

• Inpatient cost-sharing: MA plans may use daily copays for hospital stays rather than the Original Medicare deductible structure. Blood costs are still bundled into DRG-equivalent payments.
• Blood deductible: Some MA plans waive the three-pint blood deductible; others apply it. Plans must disclose blood coverage in the Evidence of Coverage.
• Outpatient transfusion: MA plans typically use copay structures for outpatient services (flat copay per transfusion visit) rather than 20 percent coinsurance.

Beneficiaries with chronic transfusion needs should review their MA plan's blood coverage carefully. The cost-sharing differences can be substantial over a year of chronic transfusion management.

GeorgiaCares SHIP (1-866-552-4464) provides free Medicare plan comparison counseling.

Coordination with Medicaid for dual-eligible beneficiaries

Dual-eligible Medicare-Medicaid beneficiaries receive substantial financial protection:

• QMB program: Medicaid covers Medicare cost-sharing for qualifying low-income beneficiaries. The Part A inpatient deductible, Part B annual deductible, coinsurance, and blood deductible are all covered for QMB beneficiaries.
• SLMB program: Covers Part B premium only (not the blood deductible).
• Medicaid coverage: Georgia Medicaid covers additional services not covered by Medicare for dual-eligible adults.

Dual-eligible beneficiaries with chronic transfusion needs typically have $0 out-of-pocket for transfusion-related care. Contact Georgia DCH Medicaid Member Services at 1-866-211-0950 for current eligibility and coverage details.

Appeals and disputes

When Medicare denies a blood-related claim, beneficiaries have access to the five-level Medicare appeals process:

1. Redetermination by the Medicare Administrative Contractor (Palmetto GBA Jurisdiction J in Georgia), submitted within 120 days of the initial denial

2. Reconsideration by a Qualified Independent Contractor (QIC), submitted within 180 days of the redetermination

3. Administrative Law Judge (ALJ) hearing, submitted within 60 days of the reconsideration

4. Medicare Appeals Council review, submitted within 60 days of the ALJ decision

5. Federal District Court, submitted within 60 days of the Council decision (subject to amount-in-controversy threshold)

For blood-related claim denials, common issues involve:

• Disputed medical necessity of transfusion (was the hemoglobin threshold appropriate?)
• Disputed coverage of autologous donation (was the autologous donation medically appropriate?)
• Disputed application of the blood deductible (were processing fees correctly excluded from the deductible?)
• Disputed coverage of specific blood components

The Medicare Rights Center (1-800-333-4114) and the Center for Medicare Advocacy (1-860-456-7790) provide free guidance on appeals. Atlanta Legal Aid Society (404-377-0701) and Georgia Legal Services Program (1-800-498-9469) provide free legal assistance to qualifying low-income beneficiaries.

At Brevy, we help Georgia families understand Medicare blood services coverage

At Brevy, we publish trustworthy, comprehensive eldercare guides for American families. Our goal is to help Georgia Medicare beneficiaries, their adult children, and the clinicians who care for them understand how Medicare's complex coverage rules work in practice. This guide on Medicare blood services is part of a broader Georgia Medicare series at brevy.com that covers the inpatient hospital benefit, outpatient hospital services, ambulatory surgical centers, physician services, anesthesia services, and many other benefit categories. We update our guides regularly as CMS issues new policy and as fee schedules, deductibles, and other thresholds change.

This guide is informational and does not constitute medical, legal, or financial advice. For specific coverage questions about your situation, contact 1-800-MEDICARE, your Medicare Administrative Contractor (Palmetto GBA at 1-877-567-9230 for Georgia), GeorgiaCares SHIP (1-866-552-4464), the Medicare Rights Center (1-800-333-4114), or a qualified Medicare counselor or attorney. For specific medical questions about transfusion appropriateness, consult your treating physician.

::: accordion

Frequently asked questions about Georgia Medicare blood services

Q1: Does Medicare cover blood transfusion?

Yes. Both Part A (inpatient) and Part B (outpatient) cover medically necessary blood transfusion. Coverage is subject to the three-pint blood deductible under Section 1813(a)(2) for Part A and Section 1833(b)(1) for Part B.

Q2: What is the three-pint blood deductible?

Medicare beneficiaries are responsible for the first three pints of whole blood (or equivalent packed red blood cells) furnished during a benefit period (Part A) or calendar year (Part B). The deductible can be satisfied by replacement (donor blood credited pint-for-pint), payment (beneficiary pays hospital charge of $40 to $80 per pint), or hospital absorption.

Q3: Has the three-pint deductible changed over time?

No. The three-pint deductible has been in the Medicare statute since the original 1965 enactment and has not been amended. While the dollar deductibles for Part A and Part B are updated annually, the blood deductible remains constant at three pints.

Q4: Do the Part A and Part B blood deductibles add together?

No. The deductibles are coordinated. Pints satisfied under one part count toward the other for the same year. The total deductible is three pints per benefit period (Part A) or calendar year (Part B), not three under each.

Q5: Are blood processing fees subject to the deductible?

No. Only the whole blood pints (or equivalent packed RBC units) are subject to the deductible. Processing fees (typing, crossmatching, leukoreduction, irradiation, administration labor) are NOT subject to the deductible and are covered from the first pint onward.

Q6: How much does a unit of blood cost?

In 2026, the hospital acquisition cost for a unit of packed red blood cells is typically $40 to $80, varying by hospital and supply contract. The total cost including processing and administration is typically $200 to $500 per unit transfused.

Q7: Are platelets subject to the blood deductible?

No. The deductible applies only to whole blood and packed RBCs. Platelets are covered under standard cost-sharing without engaging the deductible.

Q8: Is plasma subject to the blood deductible?

No. Fresh frozen plasma and other plasma components are covered under standard cost-sharing without engaging the deductible.

Q9: How does Medigap cover the blood deductible?

All standardized Medigap plans (A, B, C, D, F, G, K, L, M, N) include blood deductible coverage as one of the basic benefits. The exact coverage level varies by plan, but most plans cover the deductible in full or at substantial levels (Plans K and L at 50 to 75 percent).

Q10: Can I donate blood to satisfy my own deductible?

Yes, through the replacement pathway. The beneficiary or another donor on the beneficiary's behalf can donate replacement blood to the supplying blood bank. Each pint donated reduces the deductible by one pint. The replacement must typically occur at the specific blood bank that supplied the patient.

Q11: Why do hospitals absorb the blood cost for inpatients?

Inpatient blood costs are bundled into the DRG-based payment for the admission. The hospital receives a flat DRG amount regardless of blood used. Most hospitals administratively absorb the blood deductible rather than billing the patient separately, simplifying billing and avoiding patient friction.

Q12: When does the Part B blood deductible actually apply?

Most commonly for chronic outpatient transfusion settings: outpatient infusion centers, outpatient hospital settings for patients with MDS, chronic kidney disease anemia, or hematologic malignancies. Acute outpatient transfusions less commonly engage the deductible in practice.

Q13: Does Medicare cover autologous donation?

Yes, when medically appropriate. Pre-operative autologous donation (CPT 86890), intra-operative cell salvage (CPT 86891), and acute normovolemic hemodilution are covered when medically necessary. Routine autologous donation for low-blood-loss surgery may not be considered medically necessary.

Q14: Does Medicare cover therapeutic apheresis?

Yes. Therapeutic apheresis procedures (plasmapheresis, red cell exchange, leukapheresis, plasma pheresis) are covered under standard Part B with CPT codes 36511 through 36516 when medically necessary for appropriate indications.

Q15: What is the modern hemoglobin threshold for transfusion?

For stable hospitalized patients, the modern threshold is hemoglobin 7 to 8 g/dL. Older thresholds of 10 g/dL have been superseded by extensive clinical evidence showing equivalent or better outcomes with restrictive transfusion strategies. Symptomatic patients or those with ongoing bleeding may receive transfusion at higher thresholds.

Q16: Is my blood supply safe?

Yes. The US blood supply is the safest in history. Modern transfusion-transmitted infection rates per unit: HIV less than 1 in 1.5 million, HCV less than 1 in 1 million, HBV less than 1 in 750,000. Universal leukoreduction, nucleic acid testing, bacterial testing of platelets, and other advances have made transfusion remarkably safe.

Q17: How is blood regulated?

Federal regulation: FDA under 21 CFR Part 606 (Current Good Manufacturing Practice for Blood and Blood Components) and 21 CFR Part 640 (Additional Standards for Human Blood and Blood Products). FDA inspects blood centers regularly. CMS requires hospital transfusion services to be accredited (typically by AABB).

Q18: What blood centers serve Georgia?

American Red Cross Southeast Region (approximately 40 percent of state supply), LifeSouth Community Blood Centers, The Blood Connection, hospital-based blood banks at major systems (Emory, Wellstar, Piedmont, Augusta University Health, Memorial Health Savannah, Atrium Health Navicent), and other regional and national organizations.

Q19: How do I donate blood in Georgia?

Contact the American Red Cross (1-800-RED-CROSS), LifeSouth (1-888-795-2707), The Blood Connection (1-864-255-5000), or your local hospital blood bank. Donor eligibility includes age requirements (typically 17+ with parental consent under 17 where allowed), weight, hemoglobin, health screening, and travel/behavior deferrals.

Q20: Can Medicare Advantage plans change blood coverage?

MA plans must cover the same blood services as Original Medicare but may structure cost-sharing differently. Some MA plans waive the blood deductible; others apply standard plan cost-sharing. Beneficiaries should review their MA plan's Evidence of Coverage.

Q21: What if I need transfusions every month for chronic anemia?

Chronic outpatient transfusion is covered under Part B with the standard cost-sharing (annual Part B deductible, blood deductible for the first three pints, 20 percent coinsurance on processing and administration). Medigap typically covers all these cost-sharing obligations.

Q22: Can I appeal if Medicare denies a blood-related claim?

Yes. Five appeal levels are available through the Medicare appeals process. The Medicare Rights Center (1-800-333-4114) and Center for Medicare Advocacy (1-860-456-7790) provide free guidance.

Q23: How does coverage work for dual-eligible Medicare-Medicaid beneficiaries?

Dual-eligible beneficiaries enrolled in the Medicaid QMB program have Medicare cost-sharing (including the blood deductible) covered by Georgia Medicaid, resulting in $0 out-of-pocket for blood-related care.

Q24: What is a "spell of illness" for Part A purposes?

A spell of illness (or benefit period) begins on the first day of inpatient admission and ends after 60 consecutive days without inpatient hospital or skilled nursing facility care. The three-pint Part A blood deductible applies per spell of illness, not per calendar year.

Q25: Are factor concentrates and immune globulin subject to the blood deductible?

No. Factor concentrates (factor VIII, factor IX, etc.), albumin, and immune globulin (IVIG) are covered under Part B drug provisions with J-codes rather than as blood products subject to the deductible. :::

::: cta

Georgia blood services and Medicare contacts

Medicare and Federal

• 1-800-MEDICARE (1-800-633-4227): Medicare beneficiary services, claims, coverage questions
• Palmetto GBA Jurisdiction J: 1-877-567-9230 (Medicare Administrative Contractor for Georgia)
• Social Security Administration: 1-800-772-1213
• HHS Office for Civil Rights: 1-800-368-1019 (discrimination complaints)
• Medicare Rights Center: 1-800-333-4114 (free appeals guidance)
• Center for Medicare Advocacy: 1-860-456-7790 (free policy and appeals support)
• Kepro Quality Improvement Organization: 1-844-455-8708 (quality and appeals concerns)
• Eldercare Locator: 1-800-677-1116

Georgia State and Regional

• Georgia Department of Community Health Medicaid Member Services: 1-866-211-0950
• GeorgiaCares State Health Insurance Assistance Program (SHIP): 1-866-552-4464
• Georgia Department of Public Health: 404-657-2700
• Georgia Trauma Care Network Commission: 404-679-0540
• Georgia Office of the Attorney General Consumer Protection: 404-651-8600
• 211 Georgia (dial 211): community resource referrals
• Atlanta Legal Aid Society: 404-377-0701
• Georgia Legal Services Program: 1-800-498-9469

Blood Banking and Transfusion

• American Red Cross Southeast Region: 1-800-RED-CROSS (1-800-733-2767)
• LifeSouth Community Blood Centers: 1-888-795-2707
• The Blood Connection: 1-864-255-5000
• AABB (Association for the Advancement of Blood and Biotherapies): 301-907-6977
• VA Benefits Information: 1-800-827-1000 (for veterans with transfusion needs) :::